about
Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy.Measuring quality in electrophysiology.Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy.Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease.Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy.Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure.The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy.Intermittent Capture of the Left Bundle With Permanent His Bundle Pacing: Mechanistic Insights and Implications for an Emerging Field.T-wave alternans and ST depression assessment identifies low risk individuals with ischemic cardiomyopathy in the absence of left ventricular hypertrophy.Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes.Peeling back of left bundle branch refractoriness facilitates mapping of a hemodynamically unstable atrial flutterWhen ablating over epicardial fat, consider the path of least resistance!Non-invasively quantified changes in left ventricular activation predict outcomes in patients undergoing cardiac resynchronization therapyImplantable Cardioverter Defibrillator Lead Revision Following Left Ventricular Assist Device ImplantationWatchman implantation in a patient with left atrial appendage thrombus
P50
Q37155195-22EAACB1-F989-4FD8-9CA4-8AE4D4A9C1E9Q37441769-246C6D2C-C3F3-4F82-B897-BED49C62D907Q39036053-7E603D54-18F6-44E1-9EB0-057DB0F0BAB5Q40209669-061CBD9F-1F32-45F8-A055-8C274DDBDE3DQ40731837-441E66B9-981C-4355-9476-7CAFFAEDFD6BQ44800131-831A4F00-0FD5-4D7B-A82F-43A3387B8EC1Q46483633-960C620C-C7E6-464E-B8BE-B310D3ACF001Q46597105-48032606-9E52-4AE3-9B2B-3C95A122B0CDQ48046798-7AE510FE-377E-4AEB-95C7-0BC2A87D9345Q48446711-F93E8B53-AB65-4B55-8ED4-77103BE1C95CQ53265855-4CBA4E5F-5D2E-4F09-ADBB-08C1600DBD5BQ88479925-389FF67F-F0E6-4420-891A-C79077EAD536Q89590372-E3169831-F0FB-4975-8149-254847AF61D6Q90175819-C2F10FAB-2C86-4A18-BDA3-C1ABDA86870CQ91803230-7ABE6568-FD7C-41FB-956C-61C3553B648AQ92706223-A5021478-EC55-4F49-B710-32EFE430A45B
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Daniel J Friedman
@ast
Daniel J Friedman
@en
Daniel J Friedman
@es
Daniel J Friedman
@nl
type
label
Daniel J Friedman
@ast
Daniel J Friedman
@en
Daniel J Friedman
@es
Daniel J Friedman
@nl
prefLabel
Daniel J Friedman
@ast
Daniel J Friedman
@en
Daniel J Friedman
@es
Daniel J Friedman
@nl
P108
P1153
54997955300
P31
P496
0000-0001-5791-1954